About Sirtex Medical Limited
We are a global healthcare company with offices in the U.S., Australia, Germany, and Singapore. We develop and manufacture minimally invasive cancer and embolization therapies.
Our main product, SIR-Spheres® Y-90 resin microspheres, is a targeted radiation therapy for liver cancer. We have delivered over 150,000 doses of SIR-Spheres® in more than 50 countries. We also offer the LAVA® Liquid Embolic System and manage an Embolics portfolio, handling the entire product lifecycle from concept to launch.
We are currently involved in clinical trials for resin, CIRT, and the DOORWAY90 study. Internally, we use Quality Management Systems (QMS) and electronic QMS (eQMS) to ensure our documents are accurate, controlled, and available, meeting all regulatory and quality system requirements.
Our business development efforts focus on growing our presence in oncology and interventional radiology. We expand our product offerings and market share through partnerships, joint ventures, licensing agreements, and acquisitions.
Mission & Values
Our mission is to lead in minimally invasive cancer and embolization therapies. We partner with physicians to provide products that improve patient outcomes and simplify treatments.
Our core values include:
- Serving the medical community
- Maintaining professionalism
- Collaborating effectively
- Encouraging an entrepreneurial spirit
- Continuously innovating and improving
We are committed to creating a supportive workplace for everyone.
Team & Culture
Sirtex Medical employs between 201 and 500 individuals. The company strives to create a great workplace with a collaborative and entrepreneurial culture.
It aims to be an inclusive community where employees can work together, develop new ideas, and grow their careers. Sirtex Medical offers diverse and flexible work arrangements, including hybrid schedules for some roles, and is an equal opportunity employer.
Benefits & Perks
We offer a comprehensive benefits package to our employees. This includes:
- Eligibility for incentive programs with target bonuses
- Paid sick and vacation time
- Health insurance
- A 401k matching program
We provide competitive compensation and benefits, and we are committed to supporting ongoing professional growth and career development.
Frequently Asked Questions
Sirtex Medical offers minimally invasive cancer and embolization therapies. Its primary products include SIR-Spheres® Y-90 resin microspheres, a targeted radiation therapy for liver cancer, and the LAVA® Liquid Embolic System, which is part of their broader Embolics portfolio.
Sirtex Medical’s mission is to be at the forefront of minimally invasive cancer and embolization therapies. The company partners with physicians to provide products that enhance patient outcomes and simplify treatments.
Sirtex Medical is committed to creating a great workplace that fosters a collaborative culture and an entrepreneurial spirit. It is described as an inclusive community where employees can collaborate with talented colleagues, bring their ideas to life, and advance their careers.
Employees at Sirtex Medical are eligible to participate in incentive programs with target bonuses, paid sick and vacation time, health insurance, and a generous 401k matching program. The company also offers competitive compensation and benefits packages and is committed to ongoing professional growth and career development.
Sirtex Medical Limited has 201-500 employees.
Sirtex Medical Limited hires in 🇺🇸 United States.
Sirtex Medical Limited is not actively hiring at the moment. Check back later for new opportunities.
Yes, Sirtex Medical Limited is a remote-first company.
Sirtex Medical Limited's website is www.sirtex.com .
You can find Sirtex Medical Limited on X (Twitter) and LinkedIn .
Remote companies like Sirtex Medical Limited
Explore remote-first companies similar to Sirtex Medical Limited. Discover other top-rated employers that offer flexible schedules and work-from-anywhere options.
Day One Biopharmaceuticals
Develops targeted cancer treatments for children and adults.
Nuvalent, Inc.
Develops precisely targeted cancer therapies through structure-based drug discovery.
Ascendis Pharma
A global biopharmaceutical company developing therapies for rare endocrine diseases and cancer using its TransCon technology platform.
Silfab Solar Inc.
Designs, develops, and manufactures high-efficiency solar modules and cells for the North American market.
Freenome
Develops blood tests for early cancer detection using multiomics and machine learning.
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.